Browsing Tag
Tourmaline Bio
2 posts
Klarna storms Wall Street with $1.37bn IPO as investors bet big on BNPL 2.0
Find out how Klarna’s $1.37B IPO is reshaping fintech and igniting a U.S. IPO rebound—click to explore how the BNPL leader aims to outpace traditional banks.
Why is Novartis acquiring Tourmaline Bio—and how does pacibekitug fit into its cardiovascular pipeline?
Novartis is acquiring Tourmaline Bio in a $1.4B deal to advance pacibekitug, a promising anti-IL-6 therapy for atherosclerotic cardiovascular disease.